Happy to see our perspective on postmarket surveillance of clinical models out in NEJM!! https://ai.nejm.org/doi/full/10.1056/AIp2401116?fbclid=IwZXh0bgNhZW0CMTEAAR4OmBveDuvXhGGtbnZQwCKtDdJytEe0jVsZk44IfN8A77v4R4TKYzKqugBiyw_aem_PLU5VkMphfCMHndzh4aMYg

Comments